Beta-lactamase Producing Organisms — MCQs
All are true about ESBL except -
Which of the following is NOT a mechanism of antibiotic resistance?
Carbapenem which has a tendency to cause maximum seizures?
Which class of antibiotics is primarily inactivated by extended-spectrum β-lactamases (ESBLs)?
All the following statements are true regarding beta-lactams except:
Production of inactivating enzymes is an important mechanism of drug resistance for all of these antibiotics EXCEPT
Which of the following bacteria is classified as facultative anaerobe?
A person returns to Delhi from Bangladesh after 2 days and has diarrhea. Stool examination shows RBC's in stool. The likely organism causing is ?
The bacterial drug resistance in tuberculosis results from which mechanism?
How does Staphylococcus aureus become resistant to methicillin?
Beta-lactamase Producing Organisms Indian Medical PG Practice Questions and MCQs
Question 1: All are true about ESBL except -
- A. Resistant to carbapenems (Correct Answer)
- B. Classification is based on 3rd generation cephalosporin sensitivity
- C. Cephalosporin sensitivity testing is required to confirm ESBL
- D. Ambler classification is based on molecular structure
Explanation: ***Resistant to carbapenems*** - **ESBL (Extended-Spectrum Beta-Lactamase)**-producing bacteria are typically **susceptible to carbapenems**. Carbapenems are a primary treatment option for serious ESBL infections. - Resistance to carbapenems suggests the presence of other resistance mechanisms, such as **carbapenemases**, not ESBLs. *Classification is based on 3rd generation cephalosporin sensitivity* - ESBLs are specifically defined by their ability to hydrolyze and confer resistance to **extended-spectrum cephalosporins** (e.g., ceftriaxone, ceftazidime) and aztreonam. - This characteristic resistance to third-generation cephalosporins is key to their definition and clinical identification. *Cephalosporin sensitivity testing is required to confirm ESBL* - **Phenotypic confirmatory tests** for ESBLs involve demonstrating increased resistance to an extended-spectrum cephalosporin alone compared to the same cephalosporin combined with a **beta-lactamase inhibitor** like clavulanic acid. - This testing is crucial for accurate detection and guiding appropriate antibiotic therapy. *Ambler classification is based on molecular structure* - The **Ambler classification system** categorizes beta-lactamases into classes A, B, C, and D based on their **amino acid sequence homology** and their active site mechanisms. - This classification helps in understanding the biochemical properties and substrate profiles of different beta-lactamases, including ESBLs.
Question 2: Which of the following is NOT a mechanism of antibiotic resistance?
- A. Efflux pump activity
- B. Inactivation by enzymes such as beta-lactamase
- C. Modification of drug target sites
- D. Increased drug absorption (Correct Answer)
Explanation: ***Increased drug absorption*** - **Increased drug absorption** would lead to a higher intracellular concentration of the antibiotic, making it *more potent* against the bacteria rather than contributing to resistance. - Antibiotic resistance mechanisms aim to *reduce the effective concentration* of the drug at its target site or *alter the target itself*. *Efflux pump activity* - **Efflux pumps** are bacterial membrane proteins that actively pump antibiotics out of the bacterial cell [3]. - This mechanism *reduces the intracellular concentration* of the antibiotic, preventing it from reaching its therapeutic target [3]. *Inactivation by enzymes such as beta-lactamase* - Bacteria can produce enzymes like **beta-lactamase** that *chemically modify or degrade* the antibiotic molecule, rendering it inactive [2]. - This is a common mechanism of resistance against **beta-lactam antibiotics** (e.g., penicillin, cephalosporins) [2]. *Modification of drug target sites* - Bacteria can develop mutations that *alter the structure of the antibiotic's target site*, such as a bacterial ribosome or cell wall component [1]. - This change in the target means the antibiotic can no longer bind effectively or interfere with cellular processes, thus *losing its efficacy* [1].
Question 3: Carbapenem which has a tendency to cause maximum seizures?
- A. Imipenem (Correct Answer)
- B. Ertapenem
- C. Doripenem
- D. Meropenem
Explanation: ***Imipenem*** - **Imipenem** is associated with the highest risk of **seizures** among the carbapenems, particularly in patients with **renal impairment**, pre-existing **CNS disorders**, or high doses. - Its high affinity for **GABA-A receptors** in the central nervous system is thought to contribute to its proconvulsant effects. *Ertapenem* - While all carbapenems carry some risk of seizures, **ertapenem** has a **lower incidence** compared to imipenem. - It is often favored in patients without CNS infections or severe renal dysfunction due to its once-daily dosing. *Doripenem* - **Doripenem** also has a relatively **low risk of seizures** compared to imipenem. - It is generally well-tolerated, with side effects similar to other carbapenems but at a reduced frequency for CNS events. *Meropenem* - **Meropenem** is known to have a **lower seizure potential** than imipenem, making it a preferred choice for patients with a history of seizures or those with CNS infections. - Its **reduced affinity** for GABA-A receptors contributes to its better CNS tolerability.
Question 4: Which class of antibiotics is primarily inactivated by extended-spectrum β-lactamases (ESBLs)?
- A. Macrolides
- B. Quinolones
- C. Aminoglycosides
- D. Third-generation cephalosporins (Correct Answer)
Explanation: ***Third-generation cephalosporins*** - **ESBLs** are a group of enzymes primarily known for their ability to hydrolyze and inactivate **third-generation cephalosporins** (e.g., ceftriaxone, ceftazidime) and other beta-lactam antibiotics. - This inactivation mechanism renders agents like **ceftriaxone ineffective** against bacteria producing these enzymes, leading to significant treatment challenges. *Macrolides* - **Macrolides** (e.g., azithromycin, erythromycin) act by **inhibiting bacterial protein synthesis** through binding to the 50S ribosomal subunit. - Their mechanism of action is distinct from beta-lactam antibiotics, and they are generally **not inactivated by ESBL enzymes**. *Quinolones* - **Quinolones** (e.g., ciprofloxacin, levofloxacin) primarily function by **inhibiting bacterial DNA gyrase and topoisomerase IV**, thereby preventing DNA replication. - **ESBLs do not target quinolones**; resistance to quinolones typically arises from mutations in gyrase or efflux pump mechanisms. *Aminoglycosides* - **Aminoglycosides** (e.g., gentamicin, amikacin) are bactericidal antibiotics that **bind to the 30S ribosomal subunit**, interfering with protein synthesis. - While resistance to aminoglycosides can occur through modifying enzymes, **ESBLs do not inactivate this class of antibiotics**.
Question 5: All the following statements are true regarding beta-lactams except:
- A. Methicillin is not orally bioavailable and is given parenterally.
- B. Imipenem should be given with cilastatin
- C. Meropenem does not require cilastatin for protection against renal toxicity.
- D. Aztreonam shows cross-reactivity with cephalexin. (Correct Answer)
Explanation: ***Aztreonam shows cross-reactivity with cephalexin.*** - **Aztreonam** is a monobactam with a distinct chemical structure from other beta-lactams, resulting in a different **allergy profile** and lack of significant **cross-reactivity** with other beta-lactams, including cephalosporins like cephalexin. - Its unique structure also means it is specifically active against **gram-negative bacteria** and generally resistant to common beta-lactamases that deactivate other beta-lactams. *Imipenem should be given with cilastatin* - **Imipenem** is rapidly metabolized in the renal tubules by **dehydropeptidase-1**, leading to reduced antibiotic concentrations and potential for nephrotoxicity. - **Cilastatin** is a dehydropeptidase inhibitor that prevents the breakdown of imipenem, ensuring adequate drug levels and reducing renal damage. *Methicillin is not orally bioavailable and is given parenterally.* - **Methicillin** is an acid-labile penicillin, meaning it is extensively degraded by stomach acid when taken orally, leading to poor absorption. - Due to its instability in acidic environments, methicillin must be administered **parenterally (intravenously or intramuscularly)** to achieve therapeutic concentrations. *Meropenem does not require cilastatin for protection against renal toxicity.* - **Meropenem** is another carbapenem, but it is much more stable to metabolism by **renal dehydropeptidase-1** compared to imipenem. - This inherent stability eliminates the need for co-administration with **cilastatin** to prevent its degradation and protect against nephrotoxicity.
Question 6: Production of inactivating enzymes is an important mechanism of drug resistance for all of these antibiotics EXCEPT
- A. Quinolone (Correct Answer)
- B. Penicillin
- C. Chloramphenicol
- D. Aminoglycoside
Explanation: ***Quinolone*** - The primary mechanisms of resistance to **quinolones** involve mutations in the **gyrase** and **topoisomerase IV** enzymes or efflux pump overexpression, rather than enzymatic inactivation of the drug itself. - Unlike other antibiotic classes listed, quinolones are not typically susceptible to bacterial enzymes that degrade or modify their structure. *Penicillin* - **Penicillins** are highly susceptible to inactivation by **beta-lactamase enzymes**, which hydrolyze the beta-lactam ring, rendering the antibiotic ineffective. - This enzymatic degradation is a major mechanism of resistance developed by many bacterial species to penicillin and other beta-lactam antibiotics. *Chloramphenicol* - Resistance to **chloramphenicol** is primarily mediated by the enzyme **chloramphenicol acetyltransferase (CAT)**, which acetylates the drug, preventing its binding to the bacterial ribosome. - This enzymatic modification is a classic example of drug inactivation leading to resistance. *Aminoglycoside* - **Aminoglycosides** are frequently inactivated by a variety of **aminoglycoside-modifying enzymes (AMEs)**, such as acetyltransferases, phosphoryltransferases, and nucleotidyltransferases. - These enzymes add chemical moieties to the aminoglycoside molecule, preventing its binding to the bacterial ribosome and inhibiting protein synthesis.
Question 7: Which of the following bacteria is classified as facultative anaerobe?
- A. Bacteroides
- B. Pseudomonas
- C. Escherichia (Correct Answer)
- D. Clostridium
Explanation: ***Escherichia*** - *Escherichia coli* (E. coli) is a classic example of a **facultative anaerobe**, meaning it can grow in the presence or absence of oxygen. - It uses **aerobic respiration** when oxygen is available and switches to **fermentation** or **anaerobic respiration** in an anaerobic environment. *Bacteroides* - *Bacteroides* species are **obligate anaerobes**, meaning they can only survive and grow in the **complete absence of oxygen**. - They are a major component of the normal human gut flora and are sensitive to oxygen exposure. *Pseudomonas* - *Pseudomonas* species, such as *Pseudomonas aeruginosa*, are **obligate aerobes**, requiring **oxygen for growth and metabolism**. - They possess enzymes like cytochrome oxidase and catalase, which are essential for aerobic respiration. *Clostridium* - *Clostridium* species, like *Clostridium tetani* and *Clostridium perfringens*, are **obligate anaerobes**. - They lack the enzymes (e.g., superoxide dismutase, catalase) necessary to detoxify reactive oxygen species, making oxygen lethal to them.
Question 8: A person returns to Delhi from Bangladesh after 2 days and has diarrhea. Stool examination shows RBC's in stool. The likely organism causing is ?
- A. Enteropathogenic E. Coli
- B. Salmonella typhi
- C. Enterotoxigenic E. Coli
- D. Shigella dysenteriae (Correct Answer)
Explanation: ***Shigella dysenteriae*** - This organism causes **bacillary dysentery**, characterized by fever, abdominal cramps, and frequent, small-volume stools containing **blood and mucus (RBCs)**, which fits the clinical picture of a traveler experiencing diarrhea with RBCs in stool. - The rapid onset (within 2 days of return) and the presence of **RBCs in stool** are highly suggestive of an invasive bacterial pathogen like *Shigella*. *Enteropathogenic E. Coli* - **EPEC** typically causes **watery diarrhea**, particularly in infants, by disrupting intestinal microvilli. - It does **not usually cause bloody stools** or significant red blood cells in the stool. *Salmonella typhi* - While *Salmonella typhi* causes **typhoid fever**, its initial presentation is typically with fever, headache, and constipation, followed by a **pea-soup diarrhea** in later stages, which is usually not bloody. - The rapid onset of bloody diarrhea within 2 days is less characteristic of typhoid fever, which has a longer incubation period. *Enterotoxigenic E. Coli* - **ETEC** is a common cause of **traveler's diarrhea**, but it produces toxins that lead to **watery, non-bloody diarrhea**. - The presence of **RBCs in the stool** makes ETEC an unlikely cause in this scenario.
Question 9: The bacterial drug resistance in tuberculosis results from which mechanism?
- A. Transduction
- B. Transformation
- C. Plasmid mediated resistance
- D. Mutation (Correct Answer)
Explanation: **Explanation:** The development of drug resistance in *Mycobacterium tuberculosis* (MTB) is unique compared to many other bacteria. **Why Mutation is Correct:** In *Mycobacterium tuberculosis*, antimicrobial resistance occurs exclusively due to **spontaneous chromosomal mutations**. Unlike many Gram-negative or Gram-positive bacteria, MTB does not possess horizontal gene transfer mechanisms like plasmids or transposons. These random genetic mutations occur at a predictable frequency (e.g., 1 in $10^6$ to $10^8$ cell divisions). When a patient is treated with inadequate monotherapy or irregular dosing, these resistant mutants are "selected" and survive to multiply, leading to **acquired resistance**. **Why Incorrect Options are Wrong:** * **Transduction & Transformation (A & B):** These are forms of horizontal gene transfer involving bacteriophages and the uptake of free DNA, respectively. While common in bacteria like *Staphylococcus* or *Streptococcus*, they have no documented role in clinical drug resistance in MTB. * **Plasmid-mediated resistance (C):** Plasmids are extrachromosomal DNA elements frequently responsible for multi-drug resistance in Enterobacteriaceae (e.g., via R-plasmids). *M. tuberculosis* does not harbor resistance-carrying plasmids. **High-Yield Clinical Pearls for NEET-PG:** * **Multi-Drug Resistant TB (MDR-TB):** Defined as resistance to at least **Isoniazid (H)** and **Rifampicin (R)**. * **Genetic Targets:** * **Rifampicin resistance:** Mutation in the **rpoB** gene (beta subunit of RNA polymerase). * **Isoniazid resistance:** Mutation in **katG** (most common) or **inhA** genes. * **DOTS Strategy:** The primary reason for using "Multi-Drug Therapy" in TB is to prevent the selection of these spontaneous resistant mutants. The probability of a bacilli developing simultaneous mutations to two drugs is mathematically negligible ($10^{-6} \times 10^{-8} = 10^{-14}$).
Question 10: How does Staphylococcus aureus become resistant to methicillin?
- A. Heat shock protein
- B. Protein A
- C. Transpeptidase (Correct Answer)
- D. Protein C
Explanation: ### Explanation **1. Why Transpeptidase is Correct:** Methicillin resistance in *Staphylococcus aureus* (MRSA) is primarily mediated by the acquisition of the **mecA gene**. This gene encodes a modified **Penicillin-Binding Protein (PBP2a)**. PBPs are essentially **transpeptidases**, enzymes responsible for cross-linking the peptidoglycan layers of the bacterial cell wall. While standard PBPs are inhibited by beta-lactam antibiotics (like methicillin or oxacillin), the modified transpeptidase (PBP2a) has a **low affinity** for these drugs. This allows the bacteria to continue cell wall synthesis even in the presence of the antibiotic, leading to resistance. **2. Why Other Options are Incorrect:** * **Option A (Heat shock protein):** These are molecular chaperones that help in protein folding and stress response; they do not mediate antibiotic resistance in Staphylococci. * **Option B (Protein A):** This is a key virulence factor of *S. aureus* that binds to the **Fc portion of IgG**, preventing opsonization and phagocytosis. It is not involved in drug resistance. * **Option C (Protein C):** This is a host (human) anticoagulant protein that inactivates Factors Va and VIIIa. It has no role in bacterial physiology. **3. High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Test:** The detection of the **mecA gene** by PCR is the gold standard for identifying MRSA. * **Phenotypic Screening:** Cefoxitin disk diffusion is preferred over methicillin/oxacillin disks for screening MRSA in labs because it is a better inducer of the mecA gene. * **Drug of Choice:** **Vancomycin** is the traditional drug of choice for MRSA. For VRSA (Vancomycin-resistant), Linezolid or Daptomycin are used. * **Exceptions:** MRSA is resistant to all beta-lactams **except** 5th generation cephalosporins (e.g., **Ceftaroline**).
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free